resveratrol has been researched along with Placental Insufficiency in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bradshaw, EL; Darby, JRT; Holman, SL; Lock, MC; Macgowan, CK; McInnes, SJP; Morrison, JL; Saini, BS; Seed, M; Soo, JY; Voelcker, NH; Wiese, MD | 1 |
1 other study(ies) available for resveratrol and Placental Insufficiency
Article | Year |
---|---|
Subcutaneous maternal resveratrol treatment increases uterine artery blood flow in the pregnant ewe and increases fetal but not cardiac growth.
Topics: Animals; Blood Flow Velocity; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Cell Cycle; Delayed-Action Preparations; Female; Fetal Development; Fetal Weight; Heart; Infusions, Subcutaneous; Magnetic Resonance Imaging; Maternal Nutritional Physiological Phenomena; Myocytes, Cardiac; Placental Insufficiency; Pregnancy; Real-Time Polymerase Chain Reaction; Resveratrol; RNA, Messenger; Sheep; Sirtuin 1; TOR Serine-Threonine Kinases; Uterine Artery | 2019 |